Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
New new contracts, summarized for you
No login, no app to check — it comes to you
See who's moving and how much in your market
Senti Biosciences, Inc. Announces Oversubscribed $37.6 Million Partnership Financing
Contract Type
partnership
South San FranciscoBiotechnologyDescription
Senti Biosciences, Inc. has entered into a partnership financing with accredited investors, including Celadon Partners, New Enterprise Associates (NEA), Leaps by Bayer, Nantahala Capital, The Red Hook Fund LP, and other institutional and accredited investors. The financing is expected to raise approximately $37.6 million in gross proceeds, which will be used to fund the continued development of its SENTI-202 program, manufacturing ramp-up, research and development activities, and general corporate purposes.